Log in to save to my catalogue

A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Pr...

A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Pr...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_368f598c595b469b8b9deb6681ea6d5a

A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

[...]as the immune status of a patient or comedications change, a drug that had not appeared immunogenic for many years of treatment could begin to induce an immune response. [...]a marketed drug may exhibit IG for the first time in a new and sensitive target population, such as patients with an autoimmune disease or children. [...]bioinformatic ap...

Alternative Titles

Full title

A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_368f598c595b469b8b9deb6681ea6d5a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_368f598c595b469b8b9deb6681ea6d5a

Other Identifiers

ISSN

2163-8306

E-ISSN

2163-8306

DOI

10.1002/psp4.12465

How to access this item